![David Sherris](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Sherris
Gründer bei Paloma Pharmaceuticals, Inc.
Aktive Positionen von David Sherris
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Paloma Pharmaceuticals, Inc.
![]() Paloma Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Paloma Pharmaceuticals, Inc. manufactures pharmaceutical drugs and related products. The firm’s product Cialis which develops drugs for cancer, ocular diseases, arthritis, fibrotic diseases, antiviral, skin diseases and erectile dysfunction. The company is headquartered in Jamaica Plain, MA. | Direktor/Vorstandsmitglied | - | - |
Vorstandsvorsitzender | 01.01.2005 | - | |
Gründer | 01.01.2005 | - | |
Präsident | 01.01.2005 | - | |
Treasurer | - | - |
Karriereverlauf von David Sherris
Ehemalige bekannte Positionen von David Sherris
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
RestorGenex Corp.
![]() RestorGenex Corp. Pharmaceuticals: MajorHealth Technology RestorGenex Corp. operates as a specialty biopharmaceutical company, which focuses on developing products for dermatology, ophthalmology, and oncology. It products includes novel PI3K/Akt/mTOR pathway inhibitor which has completed two Phase I clinical trials for age-related macular degeneration and is in preclinical development in oncology, specifically glioblastoma multiforme. The company current pipeline also includes a soft anti-androgen compound for the treatment of acne vulgaris. RestorGenex was founded on March 14, 2008 and is headquartered in Buffalo Grove, IL. | Direktor/Vorstandsmitglied | 01.04.2014 | 17.06.2015 |
Technik-/Wissenschafts-/F&E-Leiter | 01.04.2014 | 08.01.2016 | |
VasculoMedics, Inc.
![]() VasculoMedics, Inc. BiotechnologyHealth Technology Part of CervoMed, Inc., VasculoMedics, Inc. is a company that produces and develops zinc finger transcription factors for medical use. The company is based in Jamaica Plain, MA. VasculoMedics was acquired by Stratus Media Group, Inc. on March 28, 2014 for $1.39 million. | Präsident | - | - |
Ausbildung von David Sherris
University of Utah | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Operativ
Director/Board Member | 2 |
President | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
RestorGenex Corp.
![]() RestorGenex Corp. Pharmaceuticals: MajorHealth Technology RestorGenex Corp. operates as a specialty biopharmaceutical company, which focuses on developing products for dermatology, ophthalmology, and oncology. It products includes novel PI3K/Akt/mTOR pathway inhibitor which has completed two Phase I clinical trials for age-related macular degeneration and is in preclinical development in oncology, specifically glioblastoma multiforme. The company current pipeline also includes a soft anti-androgen compound for the treatment of acne vulgaris. RestorGenex was founded on March 14, 2008 and is headquartered in Buffalo Grove, IL. | Health Technology |
Paloma Pharmaceuticals, Inc.
![]() Paloma Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Paloma Pharmaceuticals, Inc. manufactures pharmaceutical drugs and related products. The firm’s product Cialis which develops drugs for cancer, ocular diseases, arthritis, fibrotic diseases, antiviral, skin diseases and erectile dysfunction. The company is headquartered in Jamaica Plain, MA. | Health Technology |
VasculoMedics, Inc.
![]() VasculoMedics, Inc. BiotechnologyHealth Technology Part of CervoMed, Inc., VasculoMedics, Inc. is a company that produces and develops zinc finger transcription factors for medical use. The company is based in Jamaica Plain, MA. VasculoMedics was acquired by Stratus Media Group, Inc. on March 28, 2014 for $1.39 million. | Health Technology |
- Börse
- Insiders
- David Sherris
- Erfahrung